Learned associations between effects of abused drugs and the drug administration environment are important in drug addiction. Histochemical and electrophysiological studies suggest that these associations are encoded in sparsely distributed nucleus accumbens neurons that are selectively activated by drugs and drug-associated cues. Although correlations have been observed between nucleus accumbens neuronal activity and responsivity to drugs and drug cues, no technique exists for selectively manipulating these activated neurons and establishing their causal role in behavioral effects of drugs and drug cues. Here we describe a new approach, which we term the 'Daun02 inactivation method', that selectively inactivates a minority of neurons previously activated by cocaine in an environment repeatedly paired with cocaine to demonstrate a causal role for these activated neurons in context-specific cocaine-induced psychomotor sensitization in rats. This method provides a new tool for studying the causal roles of selectively activated neurons in behavioral effects of drugs and drug cues and in other learned behaviors.
Learned associations between the effects of abused drugs and the drug administration environment play important roles in drug addiction [1] [2] [3] [4] [5] [6] [7] [8] [9] . This form of learning involves the encoding of highly detailed information about drug effects and complex sets of cues in the drug administration environment, and it thus requires a correspondingly high degree of specificity in the underlying pattern of neural activity. Identification and manipulation of the activated neurons that mediate these learned associations are crucial to understanding the neurobiology of drug addiction.
Neuronal activity within the nucleus accumbens mediates many drugrelated learned behaviors 1, 3, 10, 11 , including context-specific psychomotor sensitization 7, 8, 12, 13 . Psychomotor sensitization refers to the progressive increase in cocaine-induced locomotor activity and stereotypy after repeated drug exposure 14, 15 , whereas 'context-specific' psychomotor sensitization refers to psychomotor sensitization that is selectively expressed in the drug-associated environmental context but not in a nondrug-paired environment [7] [8] [9] 16 . Results from histochemical studies using immediate-early gene markers of neuronal activation indicate that after repeated exposure to cocaine in a specific environmental context, only a minority of sparsely distributed accumbens neurons are selectively activated by cocaine in the drug-paired environment but not in a nondrug-paired environment [17] [18] [19] [20] . Thus context-specific neuronal activation correlates with context-specific expression of psychomotor sensitization 18 .
The implication of the above findings is that only a small number of activated nucleus accumbens neurons mediate context-specific psychomotor sensitization and other behavioral effects of drugs that are modulated by the drug administration environment. Unfortunately, current experimental methods such as brain lesioning, intracranial injections of pharmacological agents or electrical stimulation target both activated and non-activated neurons, and thus they cannot be used to selectively manipulate the activated neurons and assess a causal role for these neurons in behavior. This issue is partly addressed by in vivo electrophysiology studies that have found temporal correlations between nucleus accumbens neuronal activity and exposure to drugs or drug-associated cues [21] [22] [23] . However, results from these electrophysiology studies, like those from histochemical studies, are correlational and do not by themselves indicate whether the activated neurons play causal roles in behavior.
Here, we describe a new method, termed the 'Daun02 inactivation method' , that we used to selectively inactivate only those neurons activated by cocaine in an environment repeatedly paired with drug injections. Our results indicate that small subsets (2-3%) of nucleus accumbens neurons are selectively activated by cocaine in a specific environment and mediate context-specific psychomotor sensitization.
RESULTS
We used context-specific sensitization of cocaine-induced locomotor activity as an animal model of learned associations between the drug and its administration environment 7, 9 . In this model, cocaine is administered repeatedly to rats in a novel environment outside their home cage. Subsequent cocaine-induced locomotor responses are robustly sensitized in the drug-paired environment, but not in distinct non-drug-paired novel environments, for at least 6 months after the last cocaine exposure 9, 13, 18 . In Experiment 1, we injected one set of rats (Paired) with cocaine or saline once daily for 7 d in square locomotor activity chambers with smooth floors (context A) and another set of rats (Nonpaired) in round bowls with wood chip bedding (context B). Repeated cocaine injections increased cocaine-induced locomotor activity levels from day 1 to day 7 in the activity chambers (37%) and round bowls (39%) (data not shown). Seven days later, on test day, we injected all rats in the locomotor activity chambers with either cocaine or saline. In the paired groups (Fig. 1a) , repeated cocaine injections enhanced, and thus sensitized, cocaine-induced locomotor activity, whereas cocaine-induced locomotion was not enhanced in the non-paired groups ( Fig. 1b; threeway ANOVA interaction of prior drug exposure (cocaine, saline), test injection (cocaine, saline) and test environment (paired, non-paired): F 1,56 ¼ 8.9, P ¼ 0.004). Thus, cocaine test injections elicited a sensitized locomotor response only in the environment previously paired with repeated cocaine injections, indicating that a learned association between the effects of cocaine and the environment in which it was administered is critical for the expression of this form of sensitization.
We had previously identified a neural correlate of context-specific sensitization to cocaine in the nucleus accumbens 13 . The ability of cocaine to induce the neural activity marker Fos [24] [25] [26] [27] in nucleus accumbens is strongly enhanced for at least 6 months after sensitization in a novel environment 13, 17, 20 . Here, we found that specific environments modulate this enhanced Fos response. Repeated cocaine injections enhanced cocaine-induced Fos expression in the Paired groups (Fig. 1c) but not in the Non-paired groups ( Fig. 1d ; threeway ANOVA interaction of prior drug exposure (cocaine, saline), test injection (cocaine, saline) and test environment (paired, non-paired): F 1,55 ¼ 7.7, P ¼ 0.008). As with the locomotor response, cocaine test injections produced an enhanced Fos response only in the environment previously paired with repeated cocaine injections. Considered alongside our previous findings that the cocaine administration environment modulates not only neuronal activation but also the specific pattern of neurons that are activated during expression of contextspecific sensitization 18 , the present finding indicates that the activity of a small proportion of nucleus accumbens neurons correlates with, and could mediate, learned associations underlying this behavior.
However, it remains unknown whether these activated neurons play a causal role in mediating the context-specific sensitized response. Until now, no tools existed to selectively manipulate the small number of sparsely distributed neurons that are activated during a drug-related learned behavior. This difficulty is exemplified by the results of double labeling for Fos and the neuronal marker NeuN: only 2-3% of all nucleus accumbens neurons were activated by cocaine during the sensitized locomotor response (Fig. 1e, Supplementary Fig. 1 ). How can one manipulate these neurons without affecting the surrounding neurons? We developed a new technique for inactivating only those nucleus accumbens neurons activated during context-specific sensitized locomotion. We used c-fos-lacZ transgenic rats developed by J. Morgan and T. Curran (St. Jude Children's Hospital, Memphis, Tennessee, USA), which contain a transgene with a c-fos promoter regulating expression of the bacterial lacZ gene, encoding the protein b-galactosidase 28 (Fig. 2a) that can be detected with X-gal staining (see below and; Supplementary Fig. 2 ). When injected into cocaine-sensitized c-fos-lacZ rats in the drug-paired environment, cocaine induced b-galactosidase exclusively in Fos-expressing nucleus accumbens neurons, as determined by quantitative analysis of the colocalization of Fos and b-galactosidase in the nucleus accumbens; likewise, all Fos was expressed only in b-galactosidase nuclei (Fig. 2b) . This allowed us to use a prodrug called Daun02, which is converted by b-galactosidase to daunorubicin 29 ( Fig. 2a) -a compound shown to reduce calcium ion (Ca 2+ )-dependent action potentials in neuroblastoma cells 30 -to inactivate neurons expressing both b-galactosidase and Fos. Thus, we could selectively inactivate b-galactosidase-expressing neurons activated in the presence of cocaine and paired stimuli in the administration environment and monitor the degree of inactivation by measuring b-galactosidase expression.
The timeline for all Daun02 inactivation experiments is shown in Figure 3a . In Experiment 2, we sensitized c-fos-lacZ rats to cocaine using the same procedure described above for wild-type rats. Repeated cocaine injections increased cocaine-induced locomotor activity levels by B38% from day 1 to day 7 (F 1,58 ¼ 21.3, P o 0.0001), which is comparable to the increase seen in wild-type rats in Experiment 1. Seven days later, on induction day, we injected the rats with either cocaine to induce b-galactosidase or saline as a control that does not significantly induce b-galactosidase. Ninety minutes later, when bgalactosidase was near maximal levels, we bilaterally infused Daun02 or vehicle into the nucleus accumbens and then returned the rats to their home cages for a further 3 d to allow cell-specific inactivation to occur. On test day, we injected all rats with cocaine to allow us to assess cocaine-induced locomotor activity and nucleus accumbens b-galactosidase expression. Thus, all values shown in Figure 3b ,c indicate Nucleus accumbens injections of Daun02 attenuated cocaineinduced locomotor activity ( Fig. 3b ) in rats that previously received cocaine, but not saline, on induction day (interaction of Daun02 infusions (Daun02, vehicle) with induction-day injection (cocaine, saline): F 1,67 ¼ 5.03, P ¼ 0.028). Indeed, Daun02 reduced cocaineinduced locomotor activity to levels similar to the acute cocaine response observed on day 1 of the sensitization treatment. Daun02 also attenuated cocaine-induced b-galactosidase expression (Fig. 3c ) in rats that had previously received cocaine, but not saline, on induction day (interaction of Daun02 infusions with induction-day injection:
For perspective, when the number of b-galactosidase nuclei induced following cocaine injections (Fig. 3c ) is compared to the number induced following saline control injections (Experiment 4; Supplementary Fig. 3 ), Daun02 treatment resulted in 50% fewer b-galactosidase nuclei induced specifically by cocaine. As an anatomical control, infusions of Daun02 into caudate putamen 1 mm dorsal to our test site did not alter sensitized locomotor responses to cocaine test injections (P ¼ 0.36). In addition, when wild-type rats were treated with the same procedure used in Experiment 2, Daun02 did not have a significant effect on cocaine-induced locomotor activity, which further indicates a lack of nonspecific effects on neurons that do not produce b-galactosidase ( Supplementary Fig. 4) . Altogether, these findings demonstrate that Daun02 inactivation requires cocaineinduced b-galactosidase found in strongly activated nucleus accumbens neurons. If Daun02 had produced nonspecific inactivation of nucleus accumbens neurons, then Daun02 infusions would also have attenuated cocaine-induced locomotor activity and b-galactosidase expression in rats injected with saline on induction day, which was not the case. We next examined whether Daun02-mediated attenuation of cocaineinduced locomotion and b-galactosidase was associated with nonspecific effects in the nucleus accumbens. To assess the possibility that Daun02-mediated effects were due to generalized neurotoxicity in the accumbens, we examined cresyl violet-stained sections of nucleus accumbens from rats in Experiment 2. These sections did not show any gross alterations or decrease in size of nucleus accumbens architecture or any indication of gliosis at higher-level magnification ( Supplementary  Fig. 5 ). To examine the possibility that Daun02 effects were due to nonspecific impairments of accumbens function, we assessed the effects of Daun02 on nonspecific activation of nucleus accumbens neurons in Experiment 3. We treated rats identically to those in Experiment 2 except that we infused a mixture of AMPA and picrotoxin (a GABA A receptor antagonist) into the nucleus accumbens on test day to produce robust (over 12-fold more b-galactosidase expression than cocaine) nonspecific activation of accumbens neurons. Daun02 did not affect Figure 3 Timeline for Daun02 inactivation experiments. (a) Rats were injected once daily for 7 d with cocaine (15 mg per kg body weight (mg/kg), i.p) or saline. On induction day, after 7 d of withdrawal, the rats were injected with either cocaine (20 mg/kg) or saline. Ninety minutes later, rats received an intracranial infusion of 2 mg of Daun02 or vehicle bilaterally into the nucleus accumbens (Acb). On test day, 3 d after intracranial infusions, the rats were injected with cocaine (15 mg/kg) or saline. In Experiment 2, Daun02 attenuated cocaine-induced locomotion and b-galactosidase expression in nucleus accumbens of c-fos-lacZ rats. Rats were repeatedly injected with cocaine from day 1 to day 7, and 7 d later, on induction day, rats were injected with cocaine or saline and then given nucleus accumbens Daun02 or vehicle infusions. On test day, 3 d later, all rats were injected with cocaine. (b,c) Daun02 attenuated cocaineinduced locomotor activity (b) and nucleus accumbens b-galactosidase levels (c) on test day when rats had been previously injected with cocaine, but not saline, on induction day. Black dashed line indicates maximum levels of cocaine-induced b-galactosidase (as determined from vehicle induction group) and gray dashed line indicates baseline b-galactosidase levels (as determined from saline test injection group in Experiment 4; Supplementary Fig. 3 ). Values are expressed as mean ± s.e.m. distance traveled during 1 h following cocaine test injections (n ¼ 14-21) and mean ± s.e.m. density of b-galactosidase-labeled nuclei in nucleus accumbens (n ¼ 14-16). * indicates a significant difference relative to that in rats infused with vehicle following cocaine injections on induction day. AMPA+picrotoxin-induced locomotion ( Fig. 4a , P ¼ 0.94) or the number of b-galactosidase-labeled nuclei ( Fig. 4b , P ¼ 0.39, images in 4c). This lack of effect indicates that when cocaine was injected on induction day in Experiment 2, subsequent Daun02-dependent decreases in cocaine-induced locomotion and b-galactosidase were not due to nonspecific inactivation of accumbens neurons. Taken together, our results indicate that Daun02 inactivation after expression of contextspecific sensitization does not appear to produce significant nonspecific effects on nucleus accumbens structure and function. In Experiment 4, we assessed the effects of Daun02 inactivation on spontaneous or novelty-induced locomotor activity. Daun02 infusions on induction day did not alter locomotor activity (P ¼ 0.65) or b-galactosidase expression (P ¼ 0.72) after saline test injections ( Supplementary Fig. 3 ). This finding indicates that Daun02 inactivation of nucleus accumbens neurons is specific for only cocaine-induced locomotor activity and b-galactosidase expression.
In Experiment 5, we examined whether Daun02 inactivation was effective after an acute cocaine injection. We repeatedly injected saline, instead of cocaine, into c-fos-lacZ rats and then on induction day injected the rats with cocaine and then provided infusions of Daun02 or vehicle in the nucleus accumbens. On test day, Daun02 did not alter subsequent cocaine-induced locomotion (P ¼ 0.61; Supplementary Fig. 6 ), indicating that Daun02 inactivation requires prior sensitization to cocaine.
As shown in Experiment 1, the learned association mediating context-specific locomotor sensitization is expressed only in the cocaine-paired environment. By extension, the specific neurons mediating this learned association should also be activated only in the cocaine-paired environment. Therefore, cocaine injections in an alternate non-paired environment on induction day should not activate these context-specific activated neurons, and consequently Daun02 should not attenuate subsequent sensitized responding in the paired environment on test day. We tested this prediction in Experiment 6, in which we administered repeated cocaine injections to c-fos-lacZ rats in locomotor activity chambers (context A) according to our usual procedure, but on induction day we injected half of these rats with cocaine in the paired environment (context A) and the other half with cocaine in an alternate non-paired environment (context B) followed, in each case, by nucleus accumbens infusions of Daun02 or vehicle. On test day, we injected all rats with cocaine in context A and assessed locomotor activity. Daun02 attenuated cocaine-induced locomotor activity ( Fig. 5 ; interaction of Daun02 infusions (Daun02, vehicle) with induction-day context (A, B): F 1,55 ¼ 5.94, P ¼ 0.018) in rats that received cocaine on induction day in the paired environment (context A), but not in rats that received cocaine in the alternate non-paired environment (context B). The lack of effects from Daun02 when infused in the alternate environment indicates that the neurons selectively activated by cocaine in the cocaine-paired environment remained intact and preserved the learned association.
DISCUSSION
Our Daun02 inactivation procedure allowed us to demonstrate a causal role between a small subset of nucleus accumbens neurons selectively activated by cocaine in the drug-paired environment and context-specific locomotor sensitization to the drug. Daun02 disrupted behavior only when these neurons were activated by cocaine in the paired environment and did not produce nonspecific impairments in nucleus accumbens function or structure. We found that Daun02 was effective only when neurons were activated by injection of cocaine, but not saline, on induction day. Daun02 was effective in attenuating cocaine-induced, but not novelty-induced or AMPA+picrotoxin-induced, locomotion and accumbens activity on test day. Daun02 was effective only in reducing sensitized cocaine-induced locomotor activity but not locomotion following the first acute injection of cocaine. Most importantly, Daun02 required context-specific cocaine-induced activation of a small subset of nucleus accumbens neurons in the drug-paired environment but had no effect when cocaine was injected in an alternate non-paired environment on induction day. Overall, the dependence of Daun02 on stimuli-induced endogenous neuronal activity in behaving animals makes it possible to examine the role of context-specific activation of a small proportion of selectively activated neurons in drug-induced behavior.
The learned association between cocaine and the drug administration environment following context-specific locomotor sensitization to cocaine appears to be mediated by enhanced activation of a small number of sparsely distributed neurons in the nucleus accumbens. Results from our previous study indicate that the exact pattern of these activated neurons is determined at least in part by cocaine-induced interoceptive cues and associated environmental cues present during drug injections 18 . Following a cocaine sensitization treatment in this previous study, test injections of cocaine in the formerly cocaine-paired environment activated 87% of the same neurons that were repeatedly activated in nucleus accumbens during prior repeated cocaine administration. This overlap in activation pattern was significantly less when test injections of cocaine were administered in an alternate unpaired environment. The results from this previous study are congruent with our present results indicating that Daun02 disrupted sensitized locomotion only when cocaine was injected in the cocaine-paired environment on induction day but not when it was injected in an alternate unpaired environment. Together these studies lead us to speculate that during repeated cocaine injections in a novel environment, the learned association between environment and cocaine effects becomes encoded in specific neuronal ensembles 31, 32 .
Our Daun02 inactivation technique has the broader potential to reveal the causal roles that selectively activated subsets of neurons play in a variety of learned behaviors, such as cue-induced drug seeking [33] [34] [35] , fear conditioning 36 and spatial learning 37 . By revealing behaviorally relevant alterations produced in a small number of selected neurons, the present technique in rats and a recently reported technique in mice 38 , combined with electrophysiological and molecular characterization of these neurons during a learning task, provide new tools to study the neuronal mechanisms of learned behaviors.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
ONLINE METHODS
Subjects. Male c-fos-lacZ transgenic rats 28 and Sprague-Dawley rats (Charles River) were housed individually in standard plastic cages in a temperatureand humidity-controlled room. They were maintained on a 12 h/12 h reverse light/dark cycle (lights on at 21:00 h) and allowed free access to food and water. They were acclimatized to these housing conditions for a minimum of 7 d before drug treatments. Experimental procedures were approved by the National Institute on Drug Abuse Animal Care and Use Committee.
Experiment 1: cocaine-induced locomotor sensitization in wild-type rats. Male Sprague-Dawley rats were divided into eight groups of 7-8 rats each. We administered seven once-daily injections of cocaine (15 mg per kg body weight (mg/kg), i.p.) or saline to four groups of 'Paired' rats in locomotor activity chambers (context A: square chamber, dark, silent, smooth floor) and to four groups of 'Non-paired' rats in a distinct novel environment (context B: round chamber, brighter lighting, music by Marilyn Manson played continuously, wood chip bedding on floor). Seven days later, we placed rats in the locomotor activity chambers (context A) for 30 min and then injected all rats with cocaine (20 mg/kg, i.p.) or saline in the locomotor activity chambers and assessed locomotor activity for 60 min. Two hours after the test injections, all rats were deeply anesthetized with isoflurane and perfused transcardially with 4% paraformaldehyde.
Fos immunohistochemistry. Brain sections were processed for Fos immunohistochemistry and quantified as described previously 13, 17 . We used antibody to Fos (1:10,000 dilution of Ab-5, Calbiochem) and developed the sections using an Elite ABC kit from VectorLabs and diaminobenzidine (DAB).
Fos and NeuN double labeling. Eight more rats were treated identically to the Paired groups above, and all rats were perfused with paraformaldehyde 2 h after test injections of cocaine (20 mg/kg i.p.) or saline (n ¼ 4). The general procedure for fluorescence immunohistochemistry and quantification was similar to that described previously 18 . Sections were incubated with antibody to Fos (1:10,000 dilution of Ab-5, Calbiochem) and antibody to NeuN (1:2,000 dilution of MAB377, Chemicon) and labeled with secondary antibodies conjugated to Alexa 488 and 568 fluorophores, respectively.
b-galactosidase and Fos immunohistochemistry with c-fos-lacZ rats. We used transgenic c-fos-lacZ rats that had been bred for 35-40 generations on a Sprague-Dawley background 28 . We first examined colocalization of Fos and b-galactosidase expression in these rats. All c-fos-lacZ rats received repeated cocaine injections as described above for Paired groups. Rats were perfused with paraformaldehyde 2 h after the test injections of cocaine (20 mg/kg i.p.). Sections were incubated with antibody to Fos (1:10,000 dilution of Ab-5, Calbiochem) and polyclonal goat antibody to b-galactosidase (1:1,000 dilution of 4600-1409, Biogenesis) and labeled with secondary antibodies conjugated to Alexa 488 and 568 fluorophores, respectively. Experiments 2-6: implanting cannulae into c-fos-lacZ rats. We implanted guide cannulae into the nucleus accumbens for Daun02 inactivation experiments using previously described surgical procedures 13 . Transgenic rats (250-350 g) were anesthetized with equithesin (including 60 mg/kg sodium pentobarbital plus 225 mg/kg chloral hydrate; i.p.). For nucleus accumbens infusions, permanent guide cannulae (23 G; Plastics One) were implanted bilaterally at a 101 angle with the tip 1 mm dorsal to the nucleus accumbens; coordinates were anteroposterior +1.6 mm, mediolateral ± 3.0 mm and dorsoventral À6.0 mm relative to bregma 40 . Guide cannula coordinates for control infusions into the caudate putamen were anteroposterior +1.6 mm, mediolateral ± 3.0 mm and dorsoventral À5.0 mm relative to bregma. After cannula implantation, rats were allowed to recover for at least 5 d before experiments were begun.
Experimental procedure for Daun02 inactivation. The detailed timeline for Daun02 experiments is shown in Figure 3a . In Experiment 2, c-fos-lacZ rats received seven once-daily injections of cocaine (15 mg/kg i.p.), using the same procedure described above for Paired rats. On 'induction day' , 7 d later, we injected all rats with cocaine (20 mg/kg, i.p.) or saline in the locomotor activity chambers. Ninety minutes later, 2 mg of Daun02 (ref. 29) or vehicle (50% artificial cerebrospinal fluid (ACSF; composition in mM: NaCl, 148; KCl, 2.7; CaCl 2 , 1.2; MgCl 2 , 0.8; pH 7.4), 50% DMSO) in a 0.5-ml volume was bilaterally infused over 2 min into the nucleus accumbens or the dorsal control site (the caudate putamen). Injectors extended 1 mm beyond the end of the guide cannulae. Accumbens cannula placement was verified in cresyl violet-stained sections (Supplementary Fig. 7 ). Rats were returned to their home cages for 3 d after infusions-the 3-d time point being chosen based on unpublished pilot studies on the time course of the effectiveness of Daun02. On test day, rats were placed in locomotor activity chambers for 30 min and then injected with cocaine (15 mg/kg i.p.), and locomotor activity was monitored for 60 min. Rats were perfused with paraformaldehyde 2 h after test injections. Brain sections were processed for X-gal histochemistry. For Experiments 3-6 and wild-type controls, the same experimental timeline (for example, once-daily repeated injections, induction day and test day) and cocaine doses were used, but with the following modifications. For Experiment 3, the same procedure was used except that on test day rats were infused with AMPA (1.0 mM, 00-5, Ascent Scientific) plus picrotoxin (2.7 mM, P176, Sigma) bilaterally in the nucleus accumbens. For wild-type controls, two groups of wild-type rats were repeatedly injected with cocaine once daily for 7 d, and on induction day all rats were injected with cocaine and then given Daun02 or vehicle infusions. On test day, all rats were then injected with cocaine. In Experiment 4, rats were repeatedly injected with cocaine once daily for 7 d, and on induction day all rats were injected with cocaine and then given Daun02 or vehicle infusions. On test day, all rats were then injected with saline. In Experiment 5, rats were repeatedly injected with saline once daily for 7 d, and on induction day all rats were injected with cocaine and then given Daun02 or vehicle infusions. In Experiment 6, rats were repeatedly injected with cocaine once daily for 7 d in locomotor activity boxes (context A). On induction day, half of these rats were injected with cocaine in the round chambers (context B; described above for Experiment 1) while the other half were injected with cocaine in the activity boxes (context A). Each half was further subdivided into two groups that received either Daun02 or vehicle infusions into the nucleus accumbens. On test day, all rats were injected with cocaine in the locomotor activity boxes (context A).
X-gal histochemistry. Coronal sections (30 mm) were cut in a cryostat at À20 1C and collected in 10 mM PBS. Free-floating sections were washed three times for 10 min each in PBS and then incubated in reaction buffer (0.1 M X-gal, 100 mM sodium phosphate, 100 mM sodium chloride, 5 mM EGTA, 2 mM MgCl 2 , 0.2% Triton X-100, 0.05 M K 3 FeCN 6 , 0.05 M K 4 FeCN 6 ) for 3 h at 37 1C with gentle shaking. Sections were washed with three times for 10 min each in PBS and mounted onto chrom-alum-coated slides. Slides were dried, dehydrated through a graded series of alcohol (70%, 95%, 95%, 100% and 100% ethanol) and cleared with Citrasolv (Fisher Scientific) before coverslipping with Permount (Fisher Scientific).
Quantification of histochemical results. Bright-field images of nucleus accumbens were captured under a 5Â objective lens and digitized using a CCD camera (Coolsnap Photometrics, Roper Scientific Inc.) attached to a Zeiss Axioskop 2 light microscope. b-galactosidase-expressing nuclei characterized by blue nuclear staining were counted from these images using IPLab software for Macintosh (Scanalytics) (Supplementary Fig. 2 ). We chose a threshold level that detected moderate to darkly stained nuclei but not lightly stained nuclei. We counted nuclei from three rectangular sampling areas of 0.15 mm 2 each around the nucleus accumbens injection site from 2-3 coronal sections per rat. Image capture and quantification were conducted by an observer blind to the experimental conditions. Data analysis. Locomotor activity and histochemical data were analyzed using factorial two-or three-way analyses of variance (ANOVA). Fisher's PLSD post hoc tests were used to make specific group comparisons when appropriate. Effects were considered significant when P o 0.05. In Experiments 2-6, 12 out of the 199 rats that ran o70 m for 2 d or more during repeated cocaine injections were eliminated from the study due to abnormally low cocaine responses during sensitization. Of the remaining 187 rats, 8 rats with test-day locomotion values 2 s.d. beyond the mean were excluded. Rats were also excluded from analysis when injection sites were outside the intended boundaries, for example when they were too rostral (B2.5 mm anterior to bregma) or too caudal (B1.2 mm anterior to bregma). The rostral nucleus accumbens was chosen because nearly all cocaine-induced Fos is expressed within the rostral but not caudal portions of the nucleus accumbens 17 . Finally, we excluded rats with obvious signs of necrosis and rats that we later determined to be c-fos-lacZ negative.
